a Department of Industrial Management and Engineering , Aalto University , Espoo , Finland.
b Nordic Healthcare Group Ltd. , Helsinki , Finland.
Acta Oncol. 2018 Feb;57(2):297-303. doi: 10.1080/0284186X.2017.1343495. Epub 2017 Jul 11.
The cost of cancer and outcomes of cancer care has been much debated, since cancer represents 3-6% of total healthcare costs. The objective of this study was to analyse the development of the costs and outcomes in Finland between 2004 and 2014.
The national cost, episodes and outcomes data were obtained from the national register databases. Two hospitals were used to validate the costs of care. The outcome measures included relative survival rate, mortality, sick leave days per patient and number of new disability pensions.
The total cost of cancer in 2014 was 927 million €. The real costs increased by 1.7% per year over the period studied, while the cost per new cancer patient decreased. The relative survival rate was enhanced by 7%, and the number of sick leave days and new disability pensions per cancer patient was reduced. The share occupied by cancer treatment in total healthcare costs decreased slightly from 3.7% to 3.6%, indicating that cancer care has not become more expensive compared to the treatment of other diseases.
This is the first survey to analyse the change in actual cancer costs and outcomes in the population-level within a 10-year period. Since cancer care outcomes in Finland have been among the best in Europe, the progress in terms of the costs and the conversions in the cost distributions across categories are significant and valuable sources for international comparisons.
由于癌症占总医疗保健费用的 3-6%，因此癌症的成本和癌症护理的结果一直备受争议。本研究的目的是分析 2004 年至 2014 年期间芬兰成本和结果的发展情况。
国家成本、发病和结果数据来自国家登记数据库。使用两家医院来验证护理成本。结果测量包括相对生存率、死亡率、每位患者的病假天数和新残疾抚恤金的数量。
2014 年癌症总费用为 9.27 亿欧元。在研究期间，实际成本每年增长 1.7%，而每位新癌症患者的成本却有所下降。相对生存率提高了 7%，每位癌症患者的病假天数和新残疾抚恤金数量减少。癌症治疗在总医疗保健费用中所占的份额从 3.7%略有下降至 3.6%，表明与治疗其他疾病相比，癌症治疗的费用并未增加。
这是首次在人群水平上分析 10 年内癌症实际成本和结果变化的调查。由于芬兰的癌症护理结果一直处于欧洲最佳之列，因此在成本方面的进展以及成本在各分类之间的分配转换是具有重要意义的国际比较资源。
